ArticleCJC open2025
COVID-19 Vaccination Uptake and Myocarditis and/or Pericarditis Complications Among Chinese and South Asian Individuals in Ontario.
Article in CJC open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We previously demonstrated that the mortality rate following COVID-19 infection was higher in the Chinese population and lower in the South Asian population, compared to the general Ontario population. COVID-19 vaccines are effective in protecting against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-related diseases. Whether vaccination rates and the postvaccination risk of myocarditis and/or pericarditis are similar among ethnic groups is unclear. Methods: We conducted a population-based, retrospective cohort study using linked health datasets from Ontario to compare COVID-19 vaccination and postvaccination myocarditisand/or pericarditis rates among the Chinese, South Asian, and general populations. Populations were identified using a surname-based algorithm. The cohort was defined on December 1, 2020, coinciding with vaccine availability, and followed until June 30, 2022, for first and second dose. Myocarditis and/or pericarditis hospital admissions and emergency department visits within 42 days postvaccination were analyzed. Results: For the first dose, vaccination uptake was highest in the general population during the first 120 days. Afterwards, the Chinese and South Asian populations had a higher vaccine rate. A similar pattern was observed for the second dose. Postvaccination myocarditis and/or pericarditis rates were lower among the Chinese population (20 per 1,000,000 first doses) and the South Asian population (21 per 1,000,000 first doses), compared to that in the general population (51 per 1,000,000 first doses), with similar findings following the second dose. The standardized morbidity ratios, comparing observed vs expected myocarditis and/or pericarditis rates postvaccination were similar across the study groups. Conclusions: A time-dependent differential uptake and lower incidence of postvaccination myocarditis and/or pericarditis occurred among the Chinese and South Asian populations, compared to the general population. Our findings help inform the design of future research and health delivery programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.